Stay updated on Autologous TILs in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.

Latest updates to the Autologous TILs in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The page footer revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe site's footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record content, with the standard site header and footer. This means access to the study details is blocked and the usual study information is not visible.SummaryDifference23%

- Check47 days agoChange DetectedThe page now shows a new revision identifier (v3.7.0) replacing the previous v3.6.6, indicating an updated deployment of the page’s underlying system.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a release update. This does not modify the main content or features presented to users.SummaryDifference0.0%

- Check68 days agoChange DetectedAdds a line noting '2018 ( U.S. NIH Grant/Contract )' to the study record. This indicates NIH funding for the trial.SummaryDifference0.0%

Stay in the know with updates to Autologous TILs in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.